메뉴 건너뛰기




Volumn 30, Issue 11, 2007, Pages

Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene [1]

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; INSULIN; PANCREAS ISLET CELL ANTIBODY; SULFONYLUREA;

EID: 36049015306     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1196     Document Type: Letter
Times cited : (27)

References (3)
  • 2
    • 27744546143 scopus 로고    scopus 로고
    • the Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology: Transient neonatal diabetes is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation
    • Colombo C, Delvecchio M, Zecchino C, Faienza MF, Cavallo L, Barbetti F, the Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology: Transient neonatal diabetes is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation. Diabetologia 48:2439-2441, 2005
    • (2005) Diabetologia , vol.48 , pp. 2439-2441
    • Colombo, C.1    Delvecchio, M.2    Zecchino, C.3    Faienza, M.F.4    Cavallo, L.5    Barbetti, F.6
  • 3
    • 33846008028 scopus 로고    scopus 로고
    • Transfer to sulphonylrea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating mutations: Evidence for improvement in insulin sensitivity
    • Malecki MT, Snupien J, Klupa T, Wanic K, Mlynarski W, Gach A, Solecka I, Sieradzki J: Transfer to sulphonylrea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating mutations: evidence for improvement in insulin sensitivity. Diabetes Care 30:147-149, 2007
    • (2007) Diabetes Care , vol.30 , pp. 147-149
    • Malecki, M.T.1    Snupien, J.2    Klupa, T.3    Wanic, K.4    Mlynarski, W.5    Gach, A.6    Solecka, I.7    Sieradzki, J.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.